Articles tagged "Donation"

2018 American Transplant Congress
National Study of Living Donor Program Protocols, Processes, and Resources within U.S. Transplant Centers
D. Moore,¹ M. Dietrich,¹ P. Buerhaus,² J. Rodrigue,³ A. Minnick.¹
¹Vanderbilt University, Nashville; ²Montana State University, Bonzeman; ³Beth Israel Deaconess MC, Boston.
Purpose: There is limited research that describes living donor (LD) program processes and protocols. This study aimed to describe LD program protocols, processes, and resources…
2018 American Transplant Congress
Predicting Liver Allograft Discard: The Discard Risk Index
A. Rana, M. Kueht, N. Galvan, R. Cotton, T. Miloh, C. O'Mahony, J. Goss.
Abdominal Transplantation, Baylor College of Medicine, Houston, TX.
Background: An index that predicts liver allograft discard can effectively grade allografts and can be used to preferentially allocate marginal allografts to aggressive centers. Aim:…
2018 American Transplant Congress
Patient Attitudes and Perceptions of Using Mobile Health Technology for Living Kidney Donor Follow-Up and Care Management
A. Eno,¹ A. Thomas,¹ J. Ruck,¹ S. Rasmussen,¹ S. Halpern,¹ D. Segev,^1,2,3 M. Henderson.^1,3
¹Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD; ²Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.
Living kidney donor (LKD) follow-up is imperative to understand and monitor long-term outcomes after living donor nephrectomy, yet donor engagement with transplant hospitals post-donation remains…
2018 American Transplant Congress
Equivalent Post-Donation eGFR after Robotic Assisted versus Laparoscopic Living Donor Nephrectomy
R. Cross, H. Pollinger, M. Tan, M. Mulloy, T. Ommert, A. Ray, C. Klein.
Piedmont Transplant Institute, Atlanta, GA.
Robotic assisted donor nephrectomy (RADN) has gained popularity in recent years as a minimally invasive alternative to traditional laparoscopic donor nephrectomy (LDN). RADN offers advantages…
2018 American Transplant Congress
High GFR in Kidney Donors is Associated with Increased Risk of Proteinuria and Diabetes
D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas.
University of Minnesota, Minneapolis, MN.
Background: Measured glomerular filtration rate (GFR) has been part of the donor evaluation to rule out low GFR donors from taking undue risk for ESRD.…
2018 American Transplant Congress
Temporal Trends in Living Kidney Donor Candidates
S. Singh,^1,2 V. DiCecco,² M. Luo,² Y. Li,² O. Famure.²
¹Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada; ²Division of Nephrology and the Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Living kidney donor transplantation is the preferred treatment option for end-stage renal disease. However, living kidney donation rates have plateaued in North America. Existing studies…
2018 American Transplant Congress
Impact of Glomerular Filtration Rate Normalization to Body Surface Area on Donor Selection and Outcome in over 4000 Living Kidney Donors
S. Riad,¹ D. Keys,¹ D. Vock,¹ S. Jackson,¹ D. Berglund,¹ V. Vakil,¹ A. Matas,¹ H. Ibrahim.³
¹U of MN, Minneapolis; ²Houston Methodist, Houston.
Introduction: A donor GFR of ≥ 80 mL/min is a selection criterion. KDIGO recommends that GFR indexed to BSA should be used. Herein, we tested…
2018 American Transplant Congress
Nephrosclerosis beyond That Expected for Age is Predictive of Early New-Onset Hypertension (HTN) in Living Kidney Donors (LKD)
N. Issa,¹ L. Vaughan,¹ A. Denic,¹ V. Nagineni,¹ H. Chakkera,² J. Lieske,¹ L. Lerman,¹ S. Taler,¹ M. Stegall,¹ W. Kremers,¹ E. Poggio,³ A. Rule.¹
¹Mayo Clinic, Rochester, MN; ²Mayo Clinic, Scottsdale, AZ; ³Cleveland Clinic, Cleveland, OH.
Background: Nephrosclerosis on biopsy (bx) of LKD is associated with older age & HTN. We studied whether nephrosclerosis is predictive of adverse changes early after…
2018 American Transplant Congress
Cost Effectiveness of Hepatitis C Positive Donor Kidney Transplantation for Hepatitis C Negative Recipients with Concomitant Direct-Acting Anti-Viral Therapy
G. Gupta, Y. Zhang, H. Kale, N. Carroll, R. Sterling.
Virginia Commonwealth University, Richmond.
Background: The development of direct acting antiviral (DAA) therapy for hepatitis C virus (HCV) could allow for safe and effective treatment following renal transplantation (RT).…
2018 American Transplant Congress
Donor Safety in Obese Patients: 1038 Consecutive Robotic Living Donor Nephrectomies
C. Di Bella,¹ M. Spaggiari,¹ K. Tulla,¹ P. Di Cocco,¹ J. Oberholzer,² I. Tzvetanov,¹ E. Benedetti.¹
¹Surgery, University of Illinois, Chicago, IL; ²Surgery, University of Virginia, Virginia, VA.
Laparoscopic donor nephrectomy has been a widely accepted technical improvement in kidney transplantation. Since 2000, we have introduced robotic living donor nephrectomy (RLDN) in our…